Alerts will be sent to your verified email
Verify EmailORCHPHARMA
|
Orchid Pharma
|
Zota Health Care
|
Bliss GVS Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
4.49 % | 1.99 % | 7.3 % |
|
5yr average Equity Multiplier
|
1.61 | 1.84 | 1.28 |
|
5yr Average Asset Turnover Ratio
|
0.5 | 0.91 | 0.64 |
|
5yr Avg Net Profit Margin
|
0.56 % | -4.95 % | 9.12 % |
|
Price to Book
|
3.79 | 6.94 | 4.38 |
|
P/E
|
237.7 | 0.0 | 40.45 |
|
5yr Avg Cash Conversion Cycle
|
52.03 Days | 40.5 Days | 156.82 Days |
|
Inventory Days
|
112.47 Days | 91.82 Days | 53.4 Days |
|
Days Receivable
|
86.58 Days | 42.2 Days | 180.13 Days |
|
Days Payable
|
159.29 Days | 92.36 Days | 72.69 Days |
|
5yr Average Interest Coverage Ratio
|
3.01 | 5.98 | 14.96 |
|
5yr Avg ROCE
|
3.08 % | -2.72 % | 14.01 % |
|
5yr Avg Operating Profit Margin
|
11.84 % | 3.69 % | 16.55 % |
|
5 yr average Debt to Equity
|
0.37 | 0.04 | 0.08 |
|
5yr CAGR Net Profit
|
n/a | 206.06 % | 53.73 % |
|
5yr Average Return on Assets
|
1.2 % | -3.4 % | 5.79 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
69.84 % | 49.38 % | 35.36 % |
|
Share Pledged by Promoters
|
0.0 | 0.26 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-20.12 % | -18.74 % | 0.32 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
16.98 % | 0.37 % | 0.0 |
|
Orchid Pharma
|
Zota Health Care
|
Bliss GVS Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Asset Break-Up - Geography Wise
|
Asset Break-Up - Geography Wise
|
-
|
-
|